Streetbeat News

Stock Prices

ARCT

Arcturus Therapeutics' stock is trading higher following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 5:35 pm

ZIM

ZIM Integrated Shipping Services Ltd (NYSE:ZIM) reported a significant Q3 FY23 loss with sales down 61% Y/Y to $1.27 billion, missing estimates. The company posted an EPS loss of $(18.90) and adjusted EPS loss of $(1.71), both below expectations. Carried volume slightly increased, but average freight rate per TEU dropped by 66% Y/Y. Adjusted EBITDA plummeted by 89% Y/Y, and the company cut its FY23 outlook for adjusted EBITDA and EBIT loss. ZIM's stock price fell by 9.94% to $7.03.

Portfolio Pulse from Lekha Gupta

November 15, 2023 | 5:32 pm

CENN

CHGG

EDUC

EVTV

FFIE

FTCH

MYTE

NEGG

PIK

SOND

VLCN

WKSP

During Wednesday's intraday session, several consumer discretionary stocks experienced significant movements. Newegg Commerce (NEGG) saw a 32.1% increase, Cenntro Electric Gr (CENN) rose by 21.69%, Worksport (WKSP) went up by 21.27%, Farfetch (FTCH) increased by 17.21%, MYT Netherlands Parent (MYTE) moved upwards by 17.07%, and Chegg (CHGG) rose 16.98%. On the downside, Sonder Holdings (SOND) fell 17.5%, Volcon (VLCN) decreased by 16.71%, Faraday Future (FFIE) dropped by 12.39%, Kidpik (PIK) declined by 10.07%, Envirotech Vehicles (EVTV) went down by 8.79%, and Educational Development (EDUC) decreased by 8.72%. The movements were accompanied by significant trading volumes compared to their average, with some companies recently releasing their Q3 earnings.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:31 pm

AYTU

HRTX

KNTE

TIVC

Healthcare stocks experienced significant movement during Wednesday's intraday session. Heron Therapeutics, Kinnate Biopharma, Mira Pharmaceuticals, Cormedix, Gossamer Bio, and Evelo Biosciences saw their stocks rise following recent earnings reports. Conversely, Aytu BioPharma, Tivic Health Systems, BioCardia, TransCode Therapeutics, Homology Medicines, and Intensity Therapeutics experienced declines in their stock prices, also in the context of recent earnings releases.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:31 pm

BWEN

CLIR

ELIQ

GWAV

IDEX

IPDN

IPW

JTAI

MESA

SHPW

VTSI

In Wednesday's intraday session, several industrial stocks experienced significant movements. Babcock & Wilcox's stock surged 30.5% after their Q3 earnings report from 4 days ago. Broadwind's shares rose 20.48% following their Q3 earnings from 2 days ago. Mesa Air Gr, Ideanomics, Jet AI, and VirTra also saw their stocks rise, with VirTra's Q3 earnings released yesterday. Conversely, Electriq Power Holdings, Shapeways Holdings, Professional Diversity, Greenwave Tech Solns, ClearSign Technologies, and iPower faced declines after their recent Q3 earnings reports, with iPower's Q1 earnings also being a factor.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:31 pm

AKTS

ARQQ

ATGL

ATOM

BLBX

BTDR

CISO

DUOT

EBIX

INTZ

MLGO

PRSO

In Wednesday's intraday session, several information technology stocks experienced significant movements. CISO Global's stock surged by 63.7% following its Q3 earnings report two days ago. Ebix and Blackboxstocks also saw gains of 24.79% and 21.21%, respectively, after their Q3 earnings releases. Atomera, Akoustis Technologies, and Alpha Technology Group experienced upward movements as well. Conversely, Intrusion, Bitdeer Technologies, Arqit Quantum, Duos Technologies Group, Peraso, and MicroAlgo faced declines, with some linked to their recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:31 pm

ANSS

Over the past 5 years, Ansys (NASDAQ:ANSS) has outperformed the market with an average annual return of 14.92%, turning a $100 investment into $200.13 today. Ansys currently has a market cap of $25.88 billion.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:30 pm

SNPS

Over the past 15 years, Synopsys (NASDAQ:SNPS) has significantly outperformed the market, yielding an average annual return of 27.05%. A $100 investment in SNPS 15 years ago would now be worth $3,485.18. Synopsys currently has a market cap of $82.28 billion.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 5:30 pm

Macy's Inc (NYSE:M) stock rose 7.9% following Target Corp's better-than-expected Q3 financial results, which may indicate positive consumer spending and benefit other retailers. Target reported a slight sales dip but an increase in gross margin, suggesting a potentially favorable economic environment for retailers like Macy's.

Portfolio Pulse from Henry Khederian

November 15, 2023 | 5:28 pm

NOVT

Novanta's stock is trading higher following the announcement of its agreement to acquire Motion Solutions for $189 million.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 5:24 pm